Your browser doesn't support javascript.
loading
Cost-Effectiveness and Impact on Health Care Utilization of Interventions to Improve Medication Adherence and Outcomes in Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.
van Boven, Job F M; Lavorini, Federico; Agh, Tamas; Sadatsafavi, Mohsen; Patino, Oliver; Muresan, Bogdan.
Affiliation
  • van Boven JFM; Department of Clinical Pharmacy and Pharmacology, Groningen Research Institute for Asthma and COPD, University Medical Centre Groningen, Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: j.f.m.van.boven@rug.nl.
  • Lavorini F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Agh T; Syreon Research Institute, Budapest, Hungary; Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pecs, Pecs, Hungary.
  • Sadatsafavi M; Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Patino O; Teva Pharmaceuticals Europe BV, Amsterdam, The Netherlands.
  • Muresan B; Teva Pharmaceuticals Europe BV, Amsterdam, The Netherlands.
J Allergy Clin Immunol Pract ; 12(5): 1228-1243, 2024 May.
Article in En | MEDLINE | ID: mdl-38182099
ABSTRACT

BACKGROUND:

Poor adherence to asthma and chronic obstructive pulmonary disease maintenance therapies impairs health outcomes. Proven and cost-effective programs to promote adherence and persistence are not yet in regular widespread use. Implementation costs are a potential barrier to uptake of such programs.

OBJECTIVE:

We undertook a systematic literature review and narrative synthesis of studies investigating the cost-effectiveness of treatment adherence-promoting programs or that determined their impact on health care budget directly or via health care resource use (HCRU).

METHODS:

We identified relevant publications using Medline and PreMEDLINE (PubMed), Embase (Embase.com, Elsevier), and EconLit for publications between January 2000 and July 2021. We also searched clinical trial databases and selected conference proceedings.

RESULTS:

Of 1,910 potentially relevant articles, 26 met prespecified inclusion criteria and underwent data extraction. Eleven reported a direct assessment of adherence, 15 included economic evaluations, and 17 described HCRU. None included an analysis of biologic medication use. When they were studied, interventions were often found to be highly cost-effective, with dominant incremental cost-effectiveness ratios in some cases. Reductions in direct costs and HCRU (health care visits, hospital admissions, and/or the use of medications, including add-on/reliever treatment and antibiotics) were frequently reported. Reported use of maintenance treatments improved in some studies. Counseling and/or digitally informed programs were used in all cases in which favorable outcomes were observed.

CONCLUSIONS:

Adherence-promoting interventions are mostly cost-effective and often result in reduced HCRU and associated costs. Multidisciplinary care involving one-to-one advice and digitally enhanced communications appear to offer the greatest benefit.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Cost-Benefit Analysis / Pulmonary Disease, Chronic Obstructive / Medication Adherence Type of study: Evaluation_studies / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Implementation_research Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Cost-Benefit Analysis / Pulmonary Disease, Chronic Obstructive / Medication Adherence Type of study: Evaluation_studies / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Implementation_research Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2024 Document type: Article